CN102772620B - Medicine for inhibiting recurrence of cancer after surgery - Google Patents
Medicine for inhibiting recurrence of cancer after surgery Download PDFInfo
- Publication number
- CN102772620B CN102772620B CN201210239562.2A CN201210239562A CN102772620B CN 102772620 B CN102772620 B CN 102772620B CN 201210239562 A CN201210239562 A CN 201210239562A CN 102772620 B CN102772620 B CN 102772620B
- Authority
- CN
- China
- Prior art keywords
- cancer
- medicine
- patient
- radix
- surgery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention provides a medicine for inhibiting recurrence of cancer after surgery. The medicine is prepared by crushing and mixing 5-30g of pseudostellaria heterophylla, 5-30g of ligustrum lucidum ait, 5-30g of manyprickle acanthopanax root, 5-30g of salviae miltiorrhizae, 5-30g of pangolin, 5-30g of radix sophorae tonkinensis, 5-30g of gordon euryale and 5-30g of Chinese yam as powder to be taken by a patient. The medicine disclosed by the invention is for a patient of cancer after the surgery, with 100% of effective rate, 80% of obvious effective rate and 0% of three-year recurrence rate, and is suitable for being applied to recovery of physical strength and physiological function and resistance to reoccurrence of tumor of the patient of cancer after the surgery.
Description
Technical field
What the present invention proposed is the medicine that field of medicaments is used for the treatment of disease, specifically a kind of medicine of controlling the rear cancer return of operation.
Background technology
Cancer has become the maximum arch-criminal of harm humans health.China cancer patient has exceeded 7,500,000 at present, approximately have every year more than 130 ten thousand people to die from cancer, and its M & M is also in cumulative year after year.
In the mechanism that scientists occurs in cancer, 4 kinds of hypothesis have been proposed: i.e. gene mutation is said, immune surveillance is said, the anti-differentiation theory of cell and the juvenile cell differentiation according to α para states theory are obstructed.Relatively be recognized that at present gene mutation causes the anti-differentiation theory of cell, what make substantial progress is the discovery of oncogene.
First oncogene is found in oncogenic retrovirus, therefore again the oncogene in virus is called to viral oncogene, and the oncogene being present in people and biological normal cell is called to proto-oncogene or cellular oncogene.Constantly there is in recent years new oncogene to find.It is reported, the people oncogene of finding has at present reached over one hundred.Under normal circumstances, although in each human body, contain oncogene, in static or low expression status, not only harmless to cell, and there is important function to maintaining cell normal function, can't make people's cancer stricken.If foeign element, invades human body such as environment because of carcinogenic factors such as meals and trophic factor, chemical carcinogen, some virus, lonizing radiation, the oncogene in will active cell, causes normal cell to worsen and becomes cancerous cell.
According to existing result of study, the feature of oncogene can be summarized as follows: (1) is extensively present in biosphere, ubiquity in the cell from yeast to people.(2) during evolution, gene order is high conservative.(3) its effect embodies by its expression product protein; It is not only harmless that they are present in normal cell, and the growth of Normal Physiological Function, regulating cell and differentiation play an important role, and is that the institutes such as cell development, tissue regeneration, wound healing are essential.(4) under some factor (as lonizing radiation, some chemical substance etc.) effect, once be activated, occur quantitatively or during structural variation, will form carcinous cellular transforming gene and carcinogenic.
Through further investigation, find that the expressed protein of some oncogene may not have activity of conversion, therefore can not think that all oncogenes all have carcinogenic activity.Think at present, all somatomedin of encoding, growth factor receptors, cell internal information transmit molecule, and the gene of the transcription regulaton factor relevant with growth, all should belong to the category of oncogene.
To with the research of oncogene antioncogene in close relations be also a focus.Early stage at 20 century 70s, find that normal cell and cancerous cell merge, the hybrid cell obtaining reduces carcinogenecity or disappears.This may be the gene of preventing canceration owing to containing in normal cell, at present it is called to antioncogene.Clone first first study of tumor suppressor genes Rb the eighties in last century.Experiment showed, two allelic loss of Rb or inactivation, can cause people's cancer, and the importing of Rb gene can make some cancer reverse, even if cancerous cell " is turned over a new leaf ", becomes normal cell.The existing kind more than 10 of antioncogene of being familiar with by people at present and clone.
Some genes relevant with cancer metastasis have also been found in recent years, as the induced gene mst-1 of cancer metastasis and the most noticeable cancer metastasis suppressor gene nm23 at present.Other also has W-DNM gene, ela gene, mhc gene and determines that cancer is to be limited to part, or the gene C D shifting occurs.
The discovery of antioncogene, make we to pathogenetic understanding of tumor more comprehensively, more deep.The i.e. not only activation of oncogene, and the inactivation of antioncogene, can cause the generation of tumor.Therefore can think that the mechanism that cancer occurs is the multi-step process that an environment and heredity interacts, polygenes participates in.
The Chinese medicine of conventional treatment cancer:
Pulmonary carcinoma conventional Chinese medicine: lung heat clearing Sanjie Pill, oleum fructus bruceae soft capsule etc.
Hepatocarcinoma conventional Chinese medicine: gan fu le capsule, XIHUANG WAN etc.
Esophageal carcinoma conventional Chinese medicine: anticancer pill ball, esophagus are flat loose etc.
Gastric cancer conventional Chinese medicine: anticancer pill ball, XIAOAIPING PIAN etc.
Intestinal cancer conventional Chinese medicine: anticancer pill ball, XIHUANG WAN etc.
Breast carcinoma conventional Chinese medicine: XIHUANG WAN, FUFANG BANMAO JIAONANG etc.
Cervical cancer conventional Chinese medicine: FUFANG BANMAO JIAONANG, cinobufacin oral liquid, XIHUANG WAN etc.
Patent retrieval:
The invention belongs to the Chinese medicine for the treatment of cancer.This Chinese medicine is strengthening vital QI to eliminate pathogenic factors, qi-supplementing, blood-engendering, nourishing the liver and kidney, invigorating the spleen and regulating the stomach, anticancer removing toxic substances.Emphasis is the immunologic function of adjusting body, irrigates extremity bones of the body collectively, to nourish the vital organs of the human body.Medical material optimum weight part proportion relation in Chinese medicine of the present invention is: Radix Ginseng 15, Placenta Hominis 15, the Radix Astragali 15, Fructus Lycii 15, Radix Angelicae Sinensis 15, Flos Lonicerae 15, the Rhizoma Atractylodis Macrocephalae 15, Fructus Amomi 15, Fructus Crataegi 25.This Chinese medicine price is lower, is convenient to cancer patient and uses.
The present invention relates to a kind of Chinese medicine formula for the treatment of cancer, particularly a kind of medicine for the treatment of esophageal carcinoma, gastric cancer, intestinal cancer.Its formula is (weight portion): wild ginseng 3-5 part, Radix Astragali 20-35 part, Radix Angelicae Sinensis 5-10 part, Radix Salviae Miltiorrhizae 10-30 part, Lapis Chloriti 10-15 part, Fructus Aurantii Immaturus 8-20 part, Radix Sophorae Tonkinensis 5-10 part, Radix Linderae 5-10 part, Rhizoma Curcumae 8-15 part.Its optimum formula is than being (weight portion): 5 parts of wild ginsengs, 30 parts of the Radixs Astragali, 10 parts of Radix Angelicae Sinensis, 30 parts of Radix Salviae Miltiorrhizaes, 15 parts of Lapis Chloriti, 20 parts of Fructus Aurantii Immaturuss, 10 parts of Radix Sophorae Tonkinensiss, 10 parts of the Radixs Linderae, 15 parts of Rhizoma Curcumae, and a small amount of Mel.The pure prepared from traditional Chinese medicines of the present invention, has dissipation cancer bacterium, and softening tumor is not operated on operation, has patient's no pain without any pair work.Experimental results show that various cancers all effective in cure, particularly to esophageal carcinoma middle and advanced stage patient.
At present Chinese traditional treatment cancer has several different methods, conventionally uses traditional Chinese medicine preparation, due to cancer be that environmental factors and self heredity are closely related, so different prescription is also each variant to treatment of cancer effect not of the same race.
The Chinese medicine that is used for the treatment of at present cancer is mainly oral medication preinvasive cancer or Secondary cases cancer, but be not also specifically designed to the medicament composing prescription that maintains maintenance and Control in recurring after cancer operation, is suggested.Therefore after cancer operation, maintaining with continual cure problem is need to be anxious to be resolved.
Summary of the invention
In order to reach the object of Control in recurring after cancer operation, the present invention proposes a kind of medicine of controlling cancer return after operation.This medicine is combined by Radix Pseudostellariae, Fructus Ligustri Lucidi, Radix Et Caulis Acanthopanacis Senticosi, Radix Salviae Miltiorrhizae, Squama Manis, Radix Sophorae Tonkinensis, Semen Euryales and Rhizoma Dioscoreae, by the technical problem of cancer return after oral solution control operation.
The scheme that technical solution problem of the present invention adopts is:
By Radix Pseudostellariae, Fructus Ligustri Lucidi, Radix Et Caulis Acanthopanacis Senticosi, Radix Salviae Miltiorrhizae, Squama Manis, Radix Sophorae Tonkinensis, Semen Euryales and Rhizoma Dioscoreae each 5～30 grams, pulverize respectively, mix, make powder, for patient, take.
Good effect, medicine of the present invention is taken for cancer postoperative patient, effective percentage 100%, 80%, three year relapse rate of obvious effective rate is zero.Suitable as cancer patient after operation regain one's strength and the recurrence of physiological function and antitumor in application.
The specific embodiment
By Radix Pseudostellariae, Fructus Ligustri Lucidi, Radix Et Caulis Acanthopanacis Senticosi, Radix Salviae Miltiorrhizae, Squama Manis, Radix Sophorae Tonkinensis, Semen Euryales and Rhizoma Dioscoreae each 5～30 grams, pulverize respectively, mix, make powder, for patient, take.
The pharmacological action of medicine used:
Radix Pseudostellariae:
Nature and flavor: sweet, micro-hardship, tepor.
Gui Jing: enter the heart, spleen, lung three warps.
Effect: qi-restoratives medicine, Qi-tonifying drug.
Cure mainly: mend strengthening spleen and lung, supplementing QI for promoting the production of body fluid.Control cough due to deficiency of the lung, insufficiency of the spleen lack of appetite, cardiopalmus, palpitation with a distress feeling, edema, quenches one's thirst, and spirit is tired.
Fructus Ligustri Lucidi:
Nature and flavor: sweet in the mouth, hardship, cool in nature.
Gui Jing: liver, kidney channel.
Effect: tonifying liver kidney yin, crow must improving eyesight.
Cure mainly: modern medicine study thinks that the effect that Fructus Ligustri Lucidi can suppress helicobacter pylori can treat gastropathy, also has and suppresses the treatment of purine abnormal metabolism for gout and hyperuricemia.
Radix Et Caulis Acanthopanacis Senticosi:
Nature and flavor: acrid in the mouth, micro-hardship, slightly warm in nature.
Gui Jing: return spleen, kidney, heart channel.
Effect: there is the disorder of the body of adjusting, make it to be tending towards normal function.There is good antifatigue effect, remarkable compared with Radix Ginseng, and can significantly improve hypoxia-bearing capability.The functions such as invigorating middle warmer, benefit essence, strong will, wind-damp dispelling, strengthening bone and muscle, blood circulation and promoting silt, stomach invigorating diuresis.
Cure mainly: rehabilitation after being ill, bear too much pressure or anxiety, to work excessive, chronic disease causes weakly crowd and those need to reach very welcome self-medication medicine in the people on physiology and psychological performance peak.Support immune system, recover improper hypotension, improve blood circulation, make disorderly glycolipid metabolism normalization, liver, testis, the anabolic effect of bone density and other vitals.
Radix Salviae Miltiorrhizae:
Nature and flavor: hardship, is slightly cold.
Gui Jing: GUIXIN, Liver Channel.
Effect: promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind.
Cure mainly: menoxenia, amenorrhea dysmenorrhea, lump in the abdomen, breast ventral spine pain, pyretic arthralgia pain, skin infection swells and ache, dysphoria and insomnia, hepatosplenomegaly, angina pectoris.
Squama Manis:
Nature and flavor: salty in the mouth; Cold nature
Gui Jing: liver, stomach warp.
Effect: blood circulation promoting and dispersing pathogen accumulation, the stimulating milk secretion of stimulating the menstrual flow, eliminating carbuncle is burst hard.
Cure mainly: main blood stasis amenorrhea, lump in the abdomen, rheumatic arthralgia, agalactia, carbuncle, scrofula.
Radix Sophorae Tonkinensis:
Nature and flavor: hardship, cold, poisonous.
Gui Jing: attach to the lung and stomach meridians.
Effect: heat-clearing and toxic substances removing, detumescence sore-throat relieving.
Cure mainly: fire-toxin pents up laryngopharynx swelling and pain, gingivitis.
Semen Euryales:
Nature and flavor: sweet puckery, flat
Gui Jing: enter spleen, kidney channel.
Effect: reinforcing the kindey to control nocturnal emission, spleen reinforcing stopping leak.
Cure mainly: arthralgia chiefly caused by damp pathogen, spinal column gonalgia, invigorating middle warmer, except sudden and violent disease, the strong will of beneficial vital essence, make normal hearing and eyesight, appetizing help gas, quench the thirst.
Rhizoma Dioscoreae.
Nature and flavor: sweet in the mouth, property are put down
Gui Jing: enter lung, spleen, kidney channel.
Effect: strengthening the spleen and tonifying the lung, stomach reinforcing the kidney invigorating, the benefit of reinforcing the kidney essence, hearing-improing and eyesight improving, help the five internal organs, bone and muscle strengthening, grow that will is calmed the nerves, life lengthening.
Cure mainly: weakness of the spleen and stomach, diet reduces, loose stool diarrhoea; Women's lukorrhagia due to hypofunction of the spleen; Chronic cough of deficiency lung dry pharynx, emission due to deficiency of the kidney.Cure mainly that weakness of the spleen and stomach, lassitude, inappetence, chronic diarrhea and dysentery, insufficiency of lung-QI are dry, phlegm dyspnea cough, kidney qi loss, soreness of the waist and knees, lower limb flaccidity are weak, the red disease such as swollen, fat of the frequent micturition of quenching one's thirst, leukorrhagia nebulousurine, skin.
Synergism between medicine: utilize Radix Pseudostellariae tonify deficiency, QI invigorating, Fructus Ligustri Lucidi tonifying liver kidney yin, Radix Et Caulis Acanthopanacis Senticosi regulates body disorder, resisting fatigue, invigorating middle warmer, benefit essence, strong will, wind-damp dispelling, strengthening bone and muscle, blood circulation and promoting silt, stomach invigorating diuresis, Radix Salviae Miltiorrhizae promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, relieving restlessness clears away heart-fire, nourishing blood to tranquillize the mind, Squama Manis blood circulation promoting and dispersing pathogen accumulation, the stimulating milk secretion of stimulating the menstrual flow, eliminating carbuncle is burst hard, Radix Sophorae Tonkinensis heat-clearing and toxic substances removing, detumescence sore-throat relieving, Semen Euryales reinforcing the kindey to control nocturnal emission, spleen reinforcing stopping leak, Rhizoma Dioscoreae strengthening the spleen and tonifying the lung, stomach reinforcing the kidney invigorating, the benefit of reinforcing the kidney essence, hearing-improing and eyesight improving, help the five internal organs, bone and muscle strengthening, long will is calmed the nerves, the synergism of life lengthening, regulate patient physiological balance, improve resistance against diseases, be conducive to regain one's strength and anticancer recurrence.
Usage and consumption: medicament mixed is crushed into powder, for oral.Oral three times of patient every day, each 10～15 grams.Within 30 days, be a course for the treatment of, take continuously three courses for the treatment of or long-term taking.
Clinic trial case exemplary illustration:
1, certain man, 60 years old, gets a cancer of the stomach, through stomach resecting operation, with intestinal, coincide and be connected with esophagus, do artificial reconstructed stomach, after operation, physical weakness, diet difficulty, lethargy, weak, dose was taken medicine of the present invention after 3 months in accordance with regulations, and through examination in hospital, gastric cancer does not recur and shifts, and spirit is normal, freely, spirit is refreshing large in activity, and muscle power is strong, appetite is normal, prove that the patient after medicine of the present invention is to Surgery for Gastric Carcinoma has the effect that improves physiological function, by this patient observation of 3 years and regularly detection, do not find to recur sign.
2, certain female, 42 years old, suffer from uterus carcinoma and merge ovarian cancer, in early metaphase, by hands art, hysterectomize and ovary, after operation, carry out radiation and chemotherapy, through 3 months chemotherapy and radiations, patient body is extremely weak, alopecia, blurred vision, body nihility power, adopt medicine of the present invention to take treatment by metering, through 2 months, take medicine, the conscious physical function of patient returns to the front normal condition level of pathogenesis of cancer, tracking is followed up a case by regular visits to 4 years, through hospital diagnosis, do not find cancer return and shift sign, illustrate that medicine of the present invention has inhibitory action to uterus carcinoma and ovarian cancer, can control the recurrence of this kind of cancer.
3, certain female, 34 years old, suffer from breast cancer, after hospital diagnosis is made a definite diagnosis, carried out trouble cancer side mastectomy hands art, extract axillary lymph knot simultaneously, after operation, carried out chemicotherapy, after chemicotherapy, patient body is extremely weak, weak all over, anorexia, upon somebody's introduction, start to take the treatment that medicine of the present invention carries out Control in recurring and regains one's strength, through taking medicine after 4 months, patient body function is restored, through hospital diagnosis, do not find to recur sign, by 4 years follow up a case by regular visits to, patient does not have the clinical manifestation of breast canceration and recurrence, prove that medicine of the present invention has control effect to breast cancer relapse.
4, certain female, 72 years old, suffer from colon cancer, after hospital diagnosis, finish intestinal resection operation, and carried out artifistulation, according to doctor advised, carried out chemicotherapy, owing to suffering from colon cancer, health is caused to damage, add the injury of chemicotherapy to human body, health extreme difference after corrective surgery, and patient's fear, worry colon cancer recurrence or shift, so determine to take medicine Control in recurring of the present invention, through the medication treatment of 5 months, patient body function is restored, through hospital diagnosis, the sign that there is no recurrence and shift, tracking is followed up a case by regular visits to patient 5 years, patient is still healthy and strong, do not find colon cancer recurrence, prove that medicine of the present invention has the effect that regains one's strength and prevent recurrence to colorectal cancer patients.
5, certain man, 45 years old, patient's inappetence, blood sugar increasing, dysphoria, platelet lowers, through hospital diagnosis, find that this patient suffers from Early pancreatic carcinoma, under doctor's suggestion, determine depancreatize hands art, after operation, carried out chemicotherapy, due to after patient's pancreatectomy and chemicotherapy human physiological functions is caused to larger impact, so patient's neurolysis, health is thin and weak, weak all over, and patient is suspicious of heavy, being in fear of cancer of pancreas recurs again, so diagnose through the inventor, and the medicine that suggestion is taken the inventor and provided carries out anti-recurrence treatment, through 6 months, take medicine, patient's muscle power increases, physical function reaches recovery, using insulin to carry out sugar transforms, follow up a case by regular visits to after 3 years, diagnosis again, patient does not have other organ metastasis, and health is the same with before trouble cancer, prove that medicine of the present invention has produced drug effect for Pancreas cancer patients postoperative recovery muscle power and prevention of recurrence.
6, certain female, 53 years old, patient is conscious, and cervical region has lump, to examination in hospital cut-out lump tissue, carry out pathological analysis, be diagnosed as thyroid carcinoma, carried out immediately the resection operation of thyroid carcinoma, after operation, patient is suspicious of heavy, and frightened thyroid carcinoma recurs again, so upon somebody's introduction, take medicine of the present invention and carry out Control in recurring treatment, through taking medicine 3 years, follow the tracks of and follow up a case by regular visits to simultaneously, do not find recurrence and the transfer of thyroid carcinoma, prove that medicine of the present invention has the effect that suppresses recurrence to thyroid carcinoma.
7, certain female, 24 years old, conscious discovery stool is shapeless, row is difficulty just, after examination in hospital, be diagnosed as rectal cancer, according to doctor advised, carry out rectum canceration cutting tissue hands art, after operation, carried out chemicotherapy, after rectum canceration cutting tissue, patient is to life despair, absentminded, world-weary, be short of physical strength, asthenic body, according to household, persuade, take Chinese medicine control rectal cancer recurrence of the present invention, through successively decreasing continuously, take medicine 6 years, do not find to recur symptom, do not find to shift sign simultaneously yet, patient body functional recovery is as usual, life is filled with unbounded confidence, and marry and give birth to babies, family harmony, prove that medicine of the present invention can suppress rectal cancer recurrence, and can improve patient's mental status, make people increase life courage.
8, certain female, 68 years old, often cough, uncomfortable in chest, in expectoration, there is the blood streak, through hospital diagnosis, be that pulmonary carcinoma is early stage, carried out pulmonary's carcinoma resection operation, after operation, taken medicine Control in recurring of the present invention, through random visit, examined, pulmonary's carcinoma does not recur, but due to pulmonary's portion of tissue excision, gaseous metabolism is exerted an influence, heart has also been produced to impact simultaneously, occurred pulmonary heart disease, although take medicine, controlled the recurrence of pulmonary carcinoma, but because tissue defects causes the generation of pulmonary heart disease, survive and die of illness after 3 years.
9, certain man, 46 years old, Finding case was weak all over, anorexia, face Huang, yellowish urine, to examination in hospital, find that patient has suffered from early hepatocarcinoma, according to doctor advised, carry out liver's cancerous issue resection operation, then carried out the treatment of standard chemicotherapy, for Control in recurring, patient initiatively takes medicine of the present invention, controls the recurrence of hepatocarcinoma, through taking medicine every other month 10 courses for the treatment of, follow up a case by regular visits to 7 years, do not find recurrence and the transfer of patient's hepatocarcinoma, prove that medicine of the present invention has the effect of Control in recurring to hepatocarcinoma.
10, certain female, 43 years old, after uncomfortable, to examination in hospital, find that patient has suffered from low differentiation cervical cancer, belong to the type of cancer that is difficult to healing, but in order to extend life cycle, patient determines excision uterus, after hysterectomy, initiatively take medicine Control in recurring of the present invention, through 2 years take, although controlled the generation of position, uterus canceration, but because patient has poor differentiated carcinoma disease heredity history, arbitrarily found transfer, transfer to intestinal, and belong to multiple type, the process later stage maintains treatment, but have little effect, perform the operation latter 3 years dead, prove that medicine of the present invention has the effect that extends life cycle to this poor differentiated carcinoma disease patient, but do not have the multiple spot that can control cancerous issue to shift.
Treatment effectiveness evaluation:
By 50 routine dissimilar cancer patient's clinical trials, prove, the effective percentage that medicine of the present invention is used for the treatment of the physical rehabilitation after cancer operation reaches 100%, within 3 years, survival rate reaches 80%, simple type canceration relapse rate is zero, proves medicine of the present invention to the postoperative recovery of cancer and maintain physical function to have a significant effect.
Claims (1)
1. a medicine of controlling the rear cancer return of operation, is characterized in that: each 5～30 grams by Radix Pseudostellariae, Fructus Ligustri Lucidi, Radix Et Caulis Acanthopanacis Senticosi, Radix Salviae Miltiorrhizae, Squama Manis, Radix Sophorae Tonkinensis, Semen Euryales and Rhizoma Dioscoreae, pulverize respectively, and mix, make powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210239562.2A CN102772620B (en) | 2012-07-12 | 2012-07-12 | Medicine for inhibiting recurrence of cancer after surgery |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210239562.2A CN102772620B (en) | 2012-07-12 | 2012-07-12 | Medicine for inhibiting recurrence of cancer after surgery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102772620A CN102772620A (en) | 2012-11-14 |
| CN102772620B true CN102772620B (en) | 2014-05-07 |
Family
ID=47117877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210239562.2A Expired - Fee Related CN102772620B (en) | 2012-07-12 | 2012-07-12 | Medicine for inhibiting recurrence of cancer after surgery |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102772620B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108403775B (en) * | 2018-05-09 | 2021-05-11 | 武汉轻工大学 | Gorgon fruit shell extract for inhibiting cancer cell proliferation as well as preparation method and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101181564A (en) * | 2007-11-22 | 2008-05-21 | 西安仁仁药业有限公司 | Chinese medicine compound preparations with antineoplastic activity |
| CN102293920A (en) * | 2010-06-25 | 2011-12-28 | 上海中医药大学附属曙光医院 | Medicine composition for treating primary liver cancer and preparation method thereof |
-
2012
- 2012-07-12 CN CN201210239562.2A patent/CN102772620B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101181564A (en) * | 2007-11-22 | 2008-05-21 | 西安仁仁药业有限公司 | Chinese medicine compound preparations with antineoplastic activity |
| CN102293920A (en) * | 2010-06-25 | 2011-12-28 | 上海中医药大学附属曙光医院 | Medicine composition for treating primary liver cancer and preparation method thereof |
Non-Patent Citations (4)
| Title |
|---|
| 刘华东 * |
| 王明武.益气健脾法防治大肠癌根治术后转移复发的探讨.《湖南中医杂志》.2005,第21卷(第6期),62-63,83. |
| 益气健脾法防治大肠癌根治术后转移复发的探讨;王明武;《湖南中医杂志》;20051231;第21卷(第6期);62-63,83 * |
| 等.食管癌中医药临床治疗概述.《中医药临床杂志》.2005,第17卷(第6期),622-623. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102772620A (en) | 2012-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102228603B (en) | Chinese medicine for treating retention of urine | |
| CN103536758A (en) | Traditional Chinese medicinal composition for treating night sweat due to yin deficiency | |
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN102526566B (en) | Chinese medicine preparation for treating hysteromyoma and ovaricyst and preparation method | |
| CN103816428B (en) | A kind of preparation of effective treatment diabetes | |
| CN102600394A (en) | Traditional Chinese medicine for treating radiodermatitis | |
| CN104042891A (en) | Traditional Chinese medicine (TCM) composition for relieving constipation of puerperae and preparation method thereof | |
| CN104069162B (en) | A kind of Chinese medicine for treating urarthritis and various bone joint pains | |
| CN104740437A (en) | Traditional Chinese medicine composition for treating constipation and preparation method of traditional Chinese medicine composition | |
| CN102671135A (en) | Chinese medicinal composition for treating ovarian cyst, and preparation method thereof | |
| CN102552753B (en) | Chinese medicinal composition for treating uterine fibroid | |
| CN103330835A (en) | Traditional Chinese medicine composition for treating climacteric syndromes | |
| CN103394030B (en) | Traditional Chinese medicine composition for treating depressed liver and deficient spleen | |
| CN104042981A (en) | Medicament for treating postnatal constipation and preparation method thereof | |
| CN102772620B (en) | Medicine for inhibiting recurrence of cancer after surgery | |
| CN103251878A (en) | Anti-fatigue traditional Chinese medicine composition | |
| CN103110811B (en) | Traditional Chinese medicine composition for treating arrhythmia | |
| CN103142897B (en) | Medicine used after esophageal achalasia operation | |
| CN105169189A (en) | Medicament for treating hypothyroidism | |
| CN103263628A (en) | Traditional Chinese medicine for treating diabetes | |
| CN103751656A (en) | Traditional Chinese medicine decoction for treating turbid urea disease | |
| CN106511711A (en) | Traditional Chinese medicine formula for treating breast cancer | |
| CN101085179A (en) | Traditional Chinese medicine preparation for treating uremia | |
| CN105497823A (en) | Traditional Chinese medicine formula for treating amenorrhea | |
| CN105770834B (en) | A kind of Chinese medicinal pill for treating polymyalgia rheumatica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140507 Termination date: 20150712 |
|
| EXPY | Termination of patent right or utility model |